文献速递免疫规划卫生政策与健康促进

参与1期疫苗试验的动机:流感与埃博拉随机对照试验的比较

Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.
PubMed 文献 · Vaccine · 2018-12-07

该研究通过在线调查比较了同一中心同时招募的两项1期疫苗试验(埃博拉疫苗与佐剂季节性流感疫苗)健康参与者的参与动机。88名参与者中49人(55.7%)完成调查。两项试验中最常排在前三位的动机是:希望为他人健康做贡献、希望参与重要事项、希望推动科学进步、希望获得金钱或平板电脑等激励。尽管媒体关注和财务补偿在埃博拉疫苗试验参与者中被更频繁地提及,但利他主义和自利因素都是参与1期疫苗临床试验的重要动机。

要点

  • 利他动机(贡献他人健康、参与重要事项、推动科学)是1期疫苗试验参与者的主要动机。
  • 自利动机(金钱或实物激励)同样重要,尤其在埃博拉疫苗试验中财务补偿被更频繁提及。
  • 高关注度试验(埃博拉)与低关注度试验(流感)参与者动机谱相似,但媒体关注影响更突出。

核心结论

  • 利他主义和自利因素共同驱动健康参与者参加1期疫苗临床试验。
  • 媒体关注和财务补偿在埃博拉疫苗试验参与者中被更频繁地视为参与理由。

研究设计与样本

  • 研究为在线问卷调查,对象为加拿大哈利法克斯加拿大疫苗学中心同时招募的两项1期疫苗试验(埃博拉疫苗和佐剂季节性流感疫苗)的健康参与者。
  • 88名参与者中49人(55.7%)完成调查,其中埃博拉疫苗组22/40(55%),流感疫苗组27/48(56.3%)。

主要发现

  • 两项试验中最常排在前三位的动机为:希望为他人健康做贡献、希望参与重要事项、希望推动科学进步、希望获得金钱或平板电脑等激励。
  • 埃博拉疫苗试验参与者更频繁地提及媒体关注和财务补偿作为参与理由。

临床怎么用

  • 招募1期疫苗试验参与者时可同时强调利他意义(贡献他人健康、推动科学)和合理激励,以提高参与意愿。
  • 对于高关注度试验,媒体关注可能成为额外招募助力,但需注意平衡信息传播。

局限性

  • 样本量较小(49人完成调查),来自单一中心,结果外推需谨慎。
  • 调查为在线自报告,可能存在回忆偏倚和社会期望偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION/HYPOTHESIS: Recruitment of participants into phase 1 vaccine clinical trials can be challenging since these vaccines have not been used in humans and there is no perceived benefit to the participant. Occasionally, as was the case with a phase 1 clinical trial of an Ebola vaccine in Halifax, Canada, during the 2014-2016 West African Ebola virus outbreak, recruitment is less difficult. In this study, we explored the motivations of participants in two phase 1 vaccine trials that were concurrently enrolling at the same centre and compared the motivations of participants in a high-profile phase 1 Ebola vaccine trial to those in a less high-profile phase 1 adjuvanted seasonal influenza vaccine study. METHODS: An online survey which included participants' prior experience with clinical trials, motivations to participate (including financial incentives), and demographic information was developed to examine the motivations of healthy participants in two phase 1 clinical vaccine trials conducted at the Canadian Center for Vaccinology in Halifax, Nova Scotia. Participants were invited via email to complete the online survey. Readability and clarity were assessed through pilot testing. RESULTS: A total of 49 (55.7%) of 88 participants of the two studies completed the survey (22 [55%] of 40 participants from the Ebola vaccine study and 27 [56.3%] of 48 from the adjuvanted influenza vaccine study). Motivations that were most frequently ranked among participants' top three in both trials were (1) wanting to contribute to the health of others, (2) wanting to participate in something important, (3) wanting to contribute to the advancement of science, and (4) wanting to receive an incentive such as money or a tablet. CONCLUSIONS/RECOMMENDATIONS: Although media attention and financial compensation were more often cited by Ebola vaccine trial participants as a reason to participate, both altruistic and self-interested factors were important motivations for participants in their decision to participate in a phase 1 vaccine clinical trial.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Cattapan A, Browne K, Halperin DM, et al. Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial. Vaccine. 2018. PMID: 30528592. doi:10.1016/j.vaccine.2018.11.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。